{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:32:50Z","timestamp":1790537570020,"version":"4.1.0"},"reference-count":189,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T00:00:00Z","timestamp":1568937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008714","name":"Motor Neurone Disease Research Institute of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008714","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014012","name":"FightMND","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014012","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2019.01013","type":"journal-article","created":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T15:29:06Z","timestamp":1568993346000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":53,"title":["Kynurenine Pathway Metabolites as Biomarkers for Amyotrophic Lateral Sclerosis"],"prefix":"10.3389","volume":"13","author":[{"given":"Vanessa X.","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles J.","family":"Guillemin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,9,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1186\/s12993-015-0080-x","article-title":"Serum concentrations of kynurenines in adult patients with attention-deficit hyperactivity disorder (ADHD): a case\u2013control study.","volume":"11","author":"Aarsland","year":"2015","journal-title":"Behav. Brain Funct."},{"key":"B2","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.1158\/0008-5472.CAN-12-0549","article-title":"The Kynurenine pathway in brain tumor pathogenesis.","volume":"72","author":"Adams","year":"2012","journal-title":"Cancer Res."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112945","article-title":"Involvement of the Kynurenine pathway in human glioma pathophysiology.","volume":"9","author":"Adams","year":"2014","journal-title":"PLoS One"},{"key":"B4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bbi.2015.07.016","article-title":"Cerebrospinal fluid kynurenines in multiple sclerosis; relation to disease course and neurocognitive symptoms.","volume":"51","author":"Aeinehband","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"B5","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.nurt.2008.08.002","article-title":"ALS drug development: reflections from the past and a way forward.","volume":"5","author":"Aggarwal","year":"2008","journal-title":"Neurotherapeutics"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1177\/2472555217712659","article-title":"Microenvironment tumor metabolic interactions highlighted by qMSI: application to the Tryptophan-Kynurenine pathway in immuno-oncology.","volume":"22","author":"Ait-Belkacem","year":"2017","journal-title":"SLAS Discov."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2017-000254","article-title":"Kynurenine pathway is altered in patients with SLE and associated with severe fatigue.","volume":"5","author":"\u00c5kesson","year":"2018","journal-title":"Lupus Sci. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S1474-4422(16)30199-5","article-title":"Amyotrophic lateral sclerosis: moving towards a new classification system.","volume":"15","author":"Al-Chalabi","year":"2016","journal-title":"Lancet Neurol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1177\/1178646917691938","article-title":"Kynurenine pathway of tryptophan metabolism: regulatory and functional aspects.","volume":"10","author":"Badawy","year":"2017","journal-title":"Int. J. Tryptophan. Res."},{"key":"B10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s007020050149","article-title":"Kynurenine metabolism in Alzheimer\u2019s disease.","volume":"106","author":"Baran","year":"1999","journal-title":"J. Neural Transm."},{"key":"B11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/J.BBI.2014.07.012","article-title":"A role for inflammatory metabolites as modulators of the glutamate N-methyl-d-aspartate receptor in depression and suicidality.","volume":"43","author":"Bay-Richter","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1111\/j.1471-4159.1990.tb03143.x","article-title":"Kynurenine pathway measurements in Huntington\u2019s disease striatum: evidence for reduced formation of Kynurenic Acid.","volume":"55","author":"Beal","year":"1990","journal-title":"J. Neurochem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1038\/sj.bjp.0703250","article-title":"Role of kynurenines in the neurotoxic actions of kainic acid.","volume":"129","author":"Behan","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/0306-4522(94)90438-3","article-title":"Picolinic acid blocks the neurotoxic but not the neuroexcitant properties of quinolinic acid in the rat brain: evidence from turning behaviour and tyrosine hydroxylase immunohistochemistry.","volume":"61","author":"Beninger","year":"1994","journal-title":"Neuroscience"},{"key":"B15","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/bmc.1130040104","article-title":"Determination of urinary tryptophan and its metabolites along the nicotinic acid pathway by high performance liquid chromatography with ultraviolet detection.","volume":"4","author":"Bizzarri","year":"1990","journal-title":"Biomed. Chromatogr."},{"key":"B16","doi-asserted-by":"publisher","first-page":"9772","DOI":"10.3390\/ijms16059772","article-title":"Changing the face of Kynurenines and neurotoxicity: therapeutic considerations.","volume":"16","author":"Boh\u00e1r","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph. Lateral Scler."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.133","article-title":"An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation.","volume":"6","author":"Brundin","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1159\/000488157","article-title":"Kynurenine pathway in autism spectrum disorders in children.","volume":"76","author":"Bryn","year":"2017","journal-title":"Neuropsychobiology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JHD-160196","article-title":"Cerebrospinal fluid biomarkers for Huntington\u2019s disease.","volume":"5","author":"Byrne","year":"2016","journal-title":"J. Huntingtons Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.15252\/embj.201695810","article-title":"Brain metabolism in health, aging, and neurodegeneration.","volume":"36","author":"Camandola","year":"2017","journal-title":"EMBO J."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-25968-7","article-title":"Alterations in serum kynurenine pathway metabolites in individuals with high neocortical amyloid-\u03b2 load: a pilot study.","volume":"8","author":"Chatterjee","year":"2018","journal-title":"Sci. Rep."},{"key":"B23","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s12640-009-9129-7","article-title":"The Kynurenine pathway and inflammation in amyotropic lateral sclerosis.","volume":"18","author":"Chen","year":"2010","journal-title":"Neurotox. Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1212\/01.wnl.0000343008.26874.d1","article-title":"Epidemiology of ALS in Italy: a 10-year prospective population-based study.","volume":"72","author":"Chi\u00f2","year":"2009","journal-title":"Neurology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1046\/j.1471-4159.2003.01808.x","article-title":"Dopamine-dependent cytotoxicity of tetrahydrobiopterin: a possible mechanism for selective neurodegeneration in Parkinson\u2019s disease.","volume":"86","author":"Choi","year":"2004","journal-title":"J. Neurochem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1158\/1055-9965.EPI-13-0770","article-title":"Circulating biomarkers of tryptophan and the Kynurenine pathway and lung cancer risk.","volume":"23","author":"Chuang","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2012.00090","article-title":"A distinct profile of tryptophan metabolism along the Kynurenine pathway downstream of toll-like receptor activation in irritable Bowel Syndrome.","volume":"3","author":"Clarke","year":"2012","journal-title":"Front. Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.neuro.2012.11.007","article-title":"3-Hydroxykynurenine: an intriguing molecule exerting dual actions in the central nervous system.","volume":"34","author":"Col\u00edn-Gonz\u00e1lez","year":"2013","journal-title":"Neurotoxicology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/J.NEUROSCIENCE.2015.09.002","article-title":"Toxic synergism between quinolinic acid and organic acids accumulating in glutaric acidemia type I and in disorders of propionate metabolism in rat brain synaptosomes: relevance for metabolic acidemias.","volume":"308","author":"Col\u00edn-Gonz\u00e1lez","year":"2015","journal-title":"Neuroscience"},{"key":"B30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.pnpbp.2016.04.012","article-title":"Tryptophan via serotonin\/kynurenine pathways abnormalities in a large cohort of aggressive inmates: markers for aggression.","volume":"70","author":"Comai","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B31","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/s41586-018-0701-2","article-title":"The metabolite BH4 controls T cell proliferation in autoimmunity and cancer.","volume":"563","author":"Cronin","year":"2018","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/978-3-7091-2243-3_7","article-title":"Relationships between plasma, CSF and brain tryptophan","author":"Curzon","year":"1979","journal-title":"Transport Mechanisms of Tryptophan in Blood Cells, Nerve Cells, and at the Blood-Brain Barrier"},{"key":"B33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4137\/IJTR.S4282","article-title":"On the biological importance of the 3-hydroxyanthranilic acid: anthranilic acid ratio.","volume":"3","author":"Darlington","year":"2010","journal-title":"Int. J. Tryptophan Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1111\/j.1460-9568.2007.05838.x","article-title":"Altered kynurenine metabolism correlates with infarct volume in stroke.","volume":"26","author":"Darlington","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s12640-016-9641-5","article-title":"Kynurenines, gender and neuroinflammation; showcase Schizophrenia.","volume":"30","author":"de Bie","year":"","journal-title":"Neurotox. Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4137\/IJTR.S40332","article-title":"Progesterone alters kynurenine pathway activation in IFN-\u03b3-activated macrophages - relevance for neuroinflammatory diseases.","volume":"9","author":"de Bie","year":"","journal-title":"Int. J. Tryptophan Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jchromb.2009.01.015","article-title":"Plasma tryptophan, kynurenine and 3-hydroxykynurenine measurement using automated on-line solid-phase extraction HPLC\u2013tandem mass spectrometry.","author":"de Jong","year":"2009","journal-title":"J. Chromatogr."},{"key":"B38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/J.MEHY.2013.11.018","article-title":"Attention-deficit hyperactivity disorder (ADHD) as a pyridoxine-dependent condition: urinary diagnostic biomarkers.","volume":"82","author":"Dolina","year":"2014","journal-title":"Med. Hypotheses"},{"key":"B39","doi-asserted-by":"publisher","first-page":"11159","DOI":"10.1073\/pnas.0402026101","article-title":"Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model.","volume":"101","author":"Dupuis","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B40","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/npp.2012.248","article-title":"Connecting inflammation with glutamate agonism in suicidality.","volume":"38","author":"Erhardt","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3000632","article-title":"Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease.","volume":"2","author":"Favre","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4103\/0366-6999.149188","article-title":"Analysis of serum metabolic profile by ultra-performance liquid chromatography-mass spectrometry for biomarkers discovery: application in a pilot study to discriminate patients with tuberculosis.","volume":"128","author":"Feng","year":"2015","journal-title":"Chin. Med. J."},{"key":"B43","article-title":"Utilization of metabolomics to identify biomarkers in hematological malignancies: role of IDO and the Tryptophan pathway.","volume":"130","author":"Finger","year":"2017","journal-title":"Blood"},{"key":"B44","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0304-3940(84)90050-8","article-title":"Kynurenic acid blocks neurotoxicity and seizures induc- Ed in rats by the related brain metabolite quinolinic acid.","volume":"48","author":"Foster","year":"1984","journal-title":"Neurosci. Lett."},{"key":"B45","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s11064-006-9201-0","article-title":"Tetrahydrobiopterin availability in Parkinson\u2019s and Alzheimer\u2019s disease; potential pathogenic mechanisms.","volume":"32","author":"Foxton","year":"2007","journal-title":"Neurochem. Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1089\/jir.1990.10.599","article-title":"Immune activation and decreased tryptophan in patients with HIV-1 infection.","volume":"10","author":"Fuchs","year":"1990","journal-title":"J. Interferon Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1111\/j.1471-4159.1991.tb03460.x","article-title":"Blood? brain barrier transport of Kynurenines: implications for brain synthesis and metabolism.","volume":"56","author":"Fukui","year":"1991","journal-title":"J. Neurochem."},{"key":"B48","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1271\/bbb.68.44","article-title":"Effects of excess nicotinamide administration on the urinary excretion of nicotinamide N -Oxide and nicotinuric acid by rats.","volume":"68","author":"Fukuwatari","year":"2004","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"B49","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00702-012-0765-3","article-title":"The role of kynurenines in the pathomechanism of amyotrophic lateral sclerosis and multiple sclerosis: therapeutic implications.","volume":"119","author":"F\u00fcvesi","year":"2012","journal-title":"J. Neural Transm."},{"key":"B50","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1111\/j.1469-7610.2010.02245.x","article-title":"The possible role of the kynurenine pathway in adolescent depression with melancholic features.","volume":"51","author":"Gabbay","year":"2010","journal-title":"J. Child Psychol. Psychiatry"},{"key":"B51","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2217\/bmm.09.71","article-title":"The application of biomarkers in clinical trials for motor neuron disease.","volume":"4","author":"Ganesalingam","year":"2010","journal-title":"Biomark. Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jpsychires.2015.10.003","article-title":"Neopterin as a potential cytoprotective brain molecule.","volume":"71","author":"Ghisoni","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1080\/17482960701278562","article-title":"Disease progression and survival in ALS: first multi-state model approach Disease progression and survival in ALS: first multi-state model approach.","volume":"8","author":"Gil","year":"2017","journal-title":"Amyotroph. Lateral Scler."},{"key":"B54","first-page":"699","article-title":"Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy\/tropical spastic paraparesis, and adult T-cell leukemia\/lymphoma.","volume":"5","author":"Giusti","year":"1996","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"B55","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1515\/pterid-2014-0015","article-title":"Serum tryptophan, kynurenine, phenylalanine, tyrosine and neopterin concentrations in 100 healthy blood donors.","volume":"26","author":"Gostner","year":"2015","journal-title":"Pteridines"},{"key":"B56","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4137\/IJTR.S4779","article-title":"Kynurenine pathway metabolism is involved in the maintenance of the intracellular NAD concentration in human primary astrocytes.","volume":"3","author":"Grant","year":"2010","journal-title":"Int. J. Tryptophan Res."},{"key":"B57","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4137\/IJTR.S2469","article-title":"The physiological action of picolinic acid in the human brain.","volume":"2","author":"Grant","year":"2009","journal-title":"Int. J. Tryptophan Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1046\/j.1460-9568.1999.00806.x","article-title":"3-Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum.","volume":"11","author":"Guidetti","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1111\/j.1742-4658.2012.08485.x","article-title":"Quinolinic acid, the inescapable neurotoxin.","volume":"279","author":"Guillemin","year":"","journal-title":"FEBS J."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2012.08493.x","article-title":"Quinolinic acid: neurotoxicity.","volume":"279","author":"Guillemin","year":"","journal-title":"FEBS J."},{"key":"B61","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1365-2990.2005.00655.x","article-title":"Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer\u2019s disease hippocampus.","volume":"31","author":"Guillemin","year":"","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/bf03033781","article-title":"Involvement of quinolinic acid in AIDS dementia complex.","volume":"7","author":"Guillemin","year":"","journal-title":"Neurotox. Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/glia.20090","article-title":"Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons.","volume":"49","author":"Guillemin","year":"","journal-title":"Glia"},{"key":"B64","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/glia.10175","article-title":"Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes.","volume":"41","author":"Guillemin","year":"","journal-title":"Glia"},{"key":"B65","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-1-4615-0135-0_12","article-title":"Expression of the kynurenine pathway enzymes in human microglia and macrophages.","volume":"527","author":"Guillemin","year":"","journal-title":"Adv. Exp. Med. Biol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"12884","DOI":"10.1523\/JNEUROSCI.4101-07.2007","article-title":"Characterization of the kynurenine pathway in human neurons.","volume":"27","author":"Guillemin","year":"2007","journal-title":"J. Neurosci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1046\/j.1471-4159.2001.00498.x","article-title":"Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection.","volume":"78","author":"Guillemin","year":"2001","journal-title":"J. Neurochem."},{"key":"B68","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1179\/135100000101535375","article-title":"Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis.","volume":"5","author":"Guillemin","year":"2000","journal-title":"Redox Rep."},{"key":"B69","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.pneurobio.2005.06.001","article-title":"The physiology and pathophysiology of nitric oxide in the brain.","volume":"76","author":"Guix","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1002\/ibd.21849","article-title":"Serum analysis of tryptophan catabolism pathway: correlation with Crohn\u2019s disease activity.","volume":"18","author":"Gupta","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"key":"B71","article-title":"Amyotrophic lateral sclerosis.","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B72","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.neuint.2006.08.012","article-title":"Decreased serum and red blood cell kynurenic acid levels in Alzheimer\u2019s disease.","volume":"50","author":"Hartai","year":"2007","journal-title":"Neurochem. Int."},{"key":"B73","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/jnc.14104","article-title":"Changes in kynurenine pathway metabolism in Parkinson patients with L-DOPA-induced dyskinesia.","volume":"142","author":"Havelund","year":"2017","journal-title":"J. Neurochem."},{"key":"B74","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/978-1-4684-5952-4_94","article-title":"Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome.","volume":"294","author":"Heyes","year":"1991","journal-title":"Adv. Exp. Med. Biol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0165-5728(92)90214-6","article-title":"Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and \u03b22-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients.","volume":"40","author":"Heyes","year":"1992","journal-title":"J. Neuroimmunol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1042\/bj3260351","article-title":"Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types.","volume":"326","author":"Heyes","year":"1997","journal-title":"Biochem. J."},{"key":"B77","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/0197-0186(88)90015-0","article-title":"4-chloro-3-hydroxyanthranilate inhibits brain 3-hydroxyanthranate oxidase.","volume":"13","author":"Heyes","year":"1988","journal-title":"Neurochem. Int."},{"key":"B78","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/0003-2697(88)90556-8","article-title":"Quantification of quinolinic acid in rat brain, whole blood, and plasma by gas chromatography and negative chemical ionization mass spectrometry: effects of systemic l-tryptophan administration on brain and blood quinolinic acid concentrations.","volume":"174","author":"Heyes","year":"1988","journal-title":"Anal. Biochem."},{"key":"B79","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1007\/s00216-012-6412-x","article-title":"Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathy.","volume":"404","author":"Hirayama","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196465","article-title":"A prospective evaluation of serum kynurenine metabolites and risk of pancreatic cancer.","volume":"13","author":"Huang","year":"2018","journal-title":"PLoS One"},{"key":"B81","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1034\/j.1600-0404.2003.00076.x","article-title":"Endogenous protectant kynurenic acid in amyotrophic lateral sclerosis.","volume":"107","author":"Ilzecka","year":"2003","journal-title":"Acta Neurol. Scand."},{"key":"B82","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/dom.12171","article-title":"The importance of NAMPT\/NAD\/SIRT1 in the systemic regulation of metabolism and ageing.","volume":"15","author":"Imai","year":"2013","journal-title":"Diabetes Obes. Metab."},{"key":"B83","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2019.03.015","article-title":"Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer\u2019s disease and relationship to amyloid-\u03b2 and tau.","volume":"80","author":"Jacobs","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"B84","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.4103\/1673-5374.241446","article-title":"Inhibiting the kynurenine pathway in spinal cord injury: multiple therapeutic potentials?","volume":"13","author":"Jacobs","year":"2018","journal-title":"Neural Regen. Res."},{"key":"B85","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0006-8993(90)90826-W","article-title":"Quinolinate-induced cortical cholinergic damage: modulation by tryptophan metabolites.","volume":"529","author":"Jhamandas","year":"1990","journal-title":"Brain Res."},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/srep10466","article-title":"Prognostic significance of kynurenine 3-monooxygenase and effects on proliferation, migration and invasion of human hepatocellular carcinoma.","volume":"5","author":"Jin","year":"2015","journal-title":"Sci. Rep."},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131389","article-title":"Expression of the Kynurenine pathway in human peripheral blood mononuclear cells: implications for inflammatory and neurodegenerative disease.","volume":"10","author":"Jones","year":"2015","journal-title":"PLoS One"},{"key":"B88","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.brainres.2010.11.060","article-title":"Attenuation of proinflammatory cytokines and apoptotic process by verapamil and diltiazem against quinolinic acid induced Huntington like alterations in rats.","volume":"1372","author":"Kalonia","year":"2011","journal-title":"Brain Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s12640-012-9315-x","article-title":"Targeting neuro-inflammatory cytokines and oxidative stress by minocycline attenuates quinolinic-acid-induced Huntington\u2019s disease-like symptoms in rats.","volume":"22","author":"Kalonia","year":"2012","journal-title":"Neurotox. Res."},{"key":"B90","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4137\/IJTR.S16800","article-title":"Imbalanced kynurenine pathway in schizophrenia.","volume":"7","author":"Kegel","year":"2014","journal-title":"Int. J. Tryptophan Res."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1021\/acs.jproteome.8b00803","article-title":"Noninvasive serum metabolomic profiling reveals elevated Kynurenine pathway\u2019s metabolites in humans with prostate cancer.","volume":"18","author":"Khan","year":"2019","journal-title":"J. Proteome Res."},{"key":"B92","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/jnr.490220207","article-title":"Neurotoxic effect induced by quinolinic acid in dissociated cell culture of mouse hippocampus.","volume":"22","author":"Khaspekov","year":"1989","journal-title":"J. Neurosci. Res."},{"key":"B93","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/0306-4522(87)90066-2","article-title":"Quinolinate neurotoxicity in cortical cell culture.","volume":"23","author":"Kim","year":"1987","journal-title":"Neuroscience"},{"key":"B94","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00702-011-0668-8","article-title":"New insight into the antidepressants action: modulation of kynurenine pathway by increasing the kynurenic acid\/3-hydroxykynurenine ratio.","volume":"119","author":"Kocki","year":"2012","journal-title":"J. Neural Transm."},{"key":"B95","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1523\/jneurosci.08-06-02153.1988","article-title":"Vulnerability of cultured cortical neurons to damage by excitotoxins: differential susceptibility of neurons containing NADPH-diaphorase.","volume":"8","author":"Koh","year":"1988","journal-title":"J. Neurosci."},{"key":"B96","doi-asserted-by":"publisher","first-page":"928","DOI":"10.4269\/ajtmh.16-0037","article-title":"Plasma tryptophan and the Kynurenine\u2013tryptophan ratio are associated with the acquisition of statural growth deficits and oral vaccine underperformance in populations with environmental enteropathy.","volume":"95","author":"Kosek","year":"2016","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.ajpath.2011.05.048","article-title":"The tryptophan metabolite 3-hydroxyanthranilic acid plays anti-inflammatory and neuroprotective roles during inflammation.","volume":"179","author":"Krause","year":"2011","journal-title":"Am. J. Pathol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.3233\/JAD-170447","article-title":"Novel blood-based biomarkers of cognition, stress, and physical or cognitive training in older adults at risk of Dementia: preliminary evidence for a role of BDNF, Irisin, and the Kynurenine pathway.","volume":"59","author":"K\u00fcster","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"B99","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/J.JAD.2018.01.014","article-title":"Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-na\u00efve patients with major depressive disorder: an exploratory pilot case-control study.","volume":"231","author":"Kuwano","year":"2018","journal-title":"J. Affect. Disord."},{"key":"B100","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.tins.2007.07.002","article-title":"Heterogeneity in motoneuron disease.","volume":"30","author":"Lambrechts","year":"2007","journal-title":"Trends Neurosci."},{"key":"B101","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.neuropharm.2016.05.011","article-title":"Involvement of quinolinic acid in the neuropathogenesis of amyotrophic lateral sclerosis.","volume":"112","author":"Lee","year":"2017","journal-title":"Neuropharmacology"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1097\/QAD.0000000000001124","article-title":"Host genetic predictors of the kynurenine pathway of tryptophan catabolism among treated HIV-infected Ugandans.","volume":"30","author":"Lee","year":"2016","journal-title":"AIDS"},{"key":"B103","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neuint.2006.04.017","article-title":"In vitro evidence for an antioxidant role of 3-hydroxykynurenine and 3-hydroxyanthranilic acid in the brain.","volume":"50","author":"Leipnitz","year":"2007","journal-title":"Neurochem. Int."},{"key":"B104","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1093\/clinchem\/43.12.2397","article-title":"Diet-related reference values for plasma amino acids in newborns measured by reversed-phase HPLC.","volume":"43","author":"Lepage","year":"1997","journal-title":"Clin. Chem."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1002\/mds.25555","article-title":"3-hydroxykynurenine and other Parkinson\u2019s disease biomarkers discovered by metabolomic analysis.","volume":"28","author":"Lewitt","year":"2013","journal-title":"Mov. Disord."},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/srep41473","article-title":"Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression.","volume":"7","author":"Lim","year":"2017","journal-title":"Sci. Rep."},{"key":"B107","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/J.ICS.2007.07.011","article-title":"Characterization of the kynurenine pathway in human oligodendrocytes.","volume":"1304","author":"Lim","year":"2007","journal-title":"Int. Congr. Ser."},{"key":"B108","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4137\/IJTR.S11789","article-title":"Characterization of the kynurenine pathway and quinolinic Acid production in macaque macrophages.","volume":"6","author":"Lim","year":"2013","journal-title":"Int. J. Tryptophan Res."},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00552","article-title":"The metabolic factor Kynurenic acid of Kynurenine pathway predicts major depressive disorder.","volume":"9","author":"Liu","year":"2018","journal-title":"Front. Psychiatry"},{"key":"B110","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/J.NTT.2011.07.002","article-title":"On the antioxidant properties of kynurenic acid: free radical scavenging activity and inhibition of oxidative stress.","volume":"33","author":"Lugo-Huitr\u00f3n","year":"2011","journal-title":"Neurotoxicol. Teratol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1440-1681.2008.05077.x","article-title":"Kynurenine metabolites and inflammation markers in depressed patients treated with fluoxetine or counselling.","volume":"36","author":"Mackay","year":"2009","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.pnpbp.2010.12.017","article-title":"The new \u201c5-HT\u201d hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to th.","volume":"35","author":"Maes","year":"2011","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatry"},{"key":"B113","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/oby.20491","article-title":"Obesity-related dysregulation of the Tryptophan-Kynurenine metabolism: role of age and parameters of the metabolic syndrome.","volume":"22","author":"Mangge","year":"2014","journal-title":"Obesity"},{"key":"B114","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0003-2670(94)00493-6","article-title":"Determination of quinolinic acid in human urine by liquid chromatography with fluorimetric detection.","volume":"302","author":"Mawatari","year":"1995","journal-title":"Anal. Chim. Acta"},{"key":"B115","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/mus.10191","article-title":"Inflammatory processes in amyotrophic lateral sclerosis.","volume":"26","author":"McGeer","year":"2002","journal-title":"Muscle Nerve"},{"key":"B116","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0003-2697(68)90022-5","article-title":"Isolation and assay of radioactive urinary kynurenic and xanthurenic acids.","volume":"23","author":"McManus","year":"1968","journal-title":"Anal. Biochem."},{"key":"B117","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1136\/JCP.13.2.140","article-title":"The identification of a fluorescent reducing substance in the urine of patients with rheumatoid arthritis: the excretion of 3-hydroxyanthranilic acid in this and other conditions.","volume":"13","author":"McMillan","year":"1960","journal-title":"J. Clin. Pathol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1086\/377583","article-title":"Metabolites of the Kynurenine pathway of tryptophan metabolism in the cerebrospinal fluid of Malawian Children with Malaria.","volume":"188","author":"Medana","year":"2003","journal-title":"J. Infect. Dis."},{"key":"B119","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3945\/jn.113.189738","article-title":"Most blood biomarkers related to vitamin status, one-carbon metabolism, and the Kynurenine pathway show adequate preanalytical stability and within-person reproducibility to allow assessment of exposure or nutritional status in healthy women and cardiovascular patients.","volume":"144","author":"Midttun","year":"2014","journal-title":"J. Nutr."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.4155\/bio-2018-0044","article-title":"A validated surrogate analyte LC\u2013MS\/MS assay for quantitation of endogenous kynurenine and tryptophan in human plasma.","volume":"10","author":"Miller","year":"2018","journal-title":"Bioanalysis"},{"key":"B121","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1046\/j.1440-1711.2003.t01-1-01177.x","article-title":"Tryptophan and the immune response.","volume":"81","author":"Moffett","year":"2003","journal-title":"Immunol. Cell Biol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/BF03033242","article-title":"Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission.","volume":"10","author":"M\u00fcller","year":"2006","journal-title":"Neurotox. Res."},{"key":"B123","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/175855a0","article-title":"Isolation of Kynurenine and 3-Hydroxykynurenine from human pathological urine.","volume":"175","author":"Musajo","year":"1955","journal-title":"Nature"},{"key":"B124","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0009-8981(56)90069-9","article-title":"Excretion and isolation of kynurenine and 3-hydroxykynurenine from human pathological urine.","volume":"1","author":"Musajo","year":"1956","journal-title":"Clin. Chim. Acta"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1111\/j.1742-4658.2012.08551.x","article-title":"Kynurenines: from the perspective of major psychiatric disorders.","volume":"279","author":"Myint","year":"2012","journal-title":"FEBS J."},{"key":"B126","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1254\/jjp.71.183","article-title":"3-Hydroxykynurenine toxicity on the rat striatum in vivo.","volume":"71","author":"Nakagami","year":"1996","journal-title":"Jpn. J. Pharmacol."},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1186\/s13619-015-0019-6","article-title":"The interplay between metabolic homeostasis and neurodegeneration: insights into the neurometabolic nature of amyotrophic lateral sclerosis.","volume":"4","author":"Ngo","year":"2015","journal-title":"Cell Regen."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/AOG.0b013e318255004e","article-title":"Maternal tryptophan and kynurenine pathway metabolites and risk of preeclampsia.","volume":"119","author":"Nilsen","year":"2012","journal-title":"Obstet. Gynecol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1212\/WNL.42.9.1702","article-title":"Kynurenine pathway abnormalities in Parkinson\u2019s disease.","volume":"42","author":"Ogawa","year":"1992","journal-title":"Neurology"},{"key":"B130","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1503\/jpn.090180","article-title":"Elevated levels of kynurenic acid in the cerebrospinal fluid of patients with bipolar disorder.","volume":"35","author":"Olsson","year":"2010","journal-title":"J. Psychiatry Neurosci."},{"key":"B131","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/clinchem\/40.2.288","article-title":"Role of serotoninin the pathophysiology of depression:focus on the serotonintransporter.","volume":"40","author":"Owens","year":"1994","journal-title":"Clin. Chem."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1111\/j.1471-4159.2008.05241.x","article-title":"Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance and neurotoxicity.","volume":"105","author":"Owe-Young","year":"2008","journal-title":"J. Neurochem."},{"key":"B133","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s12035-013-8497-4","article-title":"Insulin resistance and dysregulation of tryptophan-kynurenine and kynurenine-nicotinamide adenine dinucleotide metabolic pathways.","volume":"48","author":"Oxenkrug","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"B134","article-title":"Anthranilic acid: a potential biomarker and treatment target for Schizophrenia.","volume":"4","author":"Oxenkrug","year":"2016","journal-title":"Ann. psychiatry Ment. Heal."},{"key":"B135","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1196\/annals.1403.003","article-title":"Genetic and hormonal regulation of Tryptophan-Kynurenine metabolism.","volume":"1122","author":"Oxenkrug","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B136","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00702-010-0475-7","article-title":"Interferon-gamma-inducible kynurenines\/pteridines inflammation cascade: implications for aging and aging-associated psychiatric and medical disorders NIH public access.","volume":"118","author":"Oxenkrug","year":"2011","journal-title":"J. Neural Transm."},{"key":"B137","doi-asserted-by":"publisher","first-page":"295.e2","DOI":"10.1016\/j.gie.2013.02.037","article-title":"Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine.","volume":"78","author":"Park","year":"2013","journal-title":"Gastrointest. Endosc."},{"key":"B138","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1093\/eurheartj\/eht264","article-title":"Urinary excretion of kynurenine and tryptophan, cardiovascular events, and mortality after elective coronary angiography.","volume":"34","author":"Pedersen","year":"2013","journal-title":"Eur. Heart J."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1089\/ars.2017.7145","article-title":"Nicotinamide adenine dinucleotide metabolism and neurodegeneration.","volume":"28","author":"Pehar","year":"2018","journal-title":"Antioxid. Redox Signal."},{"key":"B140","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1039\/c6nj03980d","article-title":"Dual antioxidant\/pro-oxidant behavior of the tryptophan metabolite 3-hydroxyanthranilic acid: a theoretical investigation of reaction mechanisms and kinetics.","volume":"41","author":"P\u00e9rez-Gonz\u00e1lez","year":"2017","journal-title":"New J. Chem."},{"key":"B141","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/0006-8993(82)91048-4","article-title":"An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid.","volume":"247","author":"Perkins","year":"1982","journal-title":"Brain Res."},{"key":"B142","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/nyas.12756","article-title":"mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging.","volume":"1346","author":"Perl","year":"2015","journal-title":"Ann. N. Y. Acad. Sci"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2017.00068","article-title":"ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment?.","volume":"9","author":"Petrov","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"B144","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/jnr.23494","article-title":"Quinolinic acid induces disrupts cytoskeletal homeostasis in striatal neurons. Protective role of astrocyte-neuron interaction.","volume":"93","author":"Pierozan","year":"2015","journal-title":"J. Neurosci. Res."},{"key":"B145","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.expneurol.2010.03.009","article-title":"Acute intrastriatal administration of quinolinic acid provokes hyperphosphorylation of cytoskeletal intermediate filament proteins in astrocytes and neurons of rats.","volume":"224","author":"Pierozan","year":"2010","journal-title":"Exp. Neurol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/J.METABOL.2016.05.018","article-title":"Role of metabolism in neurodegenerative disorders.","volume":"65","author":"Procaccini","year":"2016","journal-title":"Metabolism"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122046","article-title":"Accumulation of an endogenous tryptophan-derived metabolite in colorectal and breast cancers.","volume":"10","author":"Puccetti","year":"2015","journal-title":"PLoS One"},{"key":"B148","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1042\/bj0910137","article-title":"Effect of 3-Hydroxyanthranilic acid on the mitochondrial respiratory system.","volume":"91","author":"Quagliariello","year":"1964","journal-title":"Biochem J."},{"key":"B149","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0304-3940(02)00710-3","article-title":"Decreased level of kynurenic acid in cerebrospinal fluid of relapsing-onset multiple sclerosis patients.","volume":"331","author":"Rejdak","year":"2002","journal-title":"Neurosci. Lett."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1111\/j.1471-4159.2006.04199.x","article-title":"Evidence that quinolinic acid severely impairs energy metabolism through activation of NMDA receptors in striatum from developing rats.","volume":"99","author":"Ribeiro","year":"2006","journal-title":"J. Neurochem."},{"key":"B151","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/s1462399406000068","article-title":"Tryptophan metabolism in the central nervous system: medical implications.","volume":"8","author":"Ruddick","year":"2006","journal-title":"Expert Rev. Mol. Med."},{"key":"B152","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1046\/j.1471-4159.1995.65020895.x","article-title":"Parallel induction of nitric oxide and tetrahydrobiopterin synthesis by cytokines in rat glial cells.","volume":"65","author":"Sakai","year":"1995","journal-title":"J. Neurochem."},{"key":"B153","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1080\/00207450600754087","article-title":"Serotonergic mechanisms in amyotrophic lateral sclerosis.","volume":"116","author":"Sandyk","year":"2006","journal-title":"Int. J. Neurosci."},{"key":"B154","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1046\/j.1471-4159.1995.64020932.x","article-title":"Increased concentrations of the Neurotoxin 3-Hydroxykynurenine in the frontal cortex of HIV-1-positive patients.","volume":"64","author":"Sardar","year":"2002","journal-title":"J. Neurochem."},{"key":"B155","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.neures.2018.07.001","article-title":"Metabolic aspects of neuronal degeneration: from a NAD+ point of view.","volume":"139","author":"Sasaki","year":"2019","journal-title":"Neurosci. Res."},{"key":"B156","doi-asserted-by":"publisher","first-page":"8484","DOI":"10.1523\/JNEUROSCI.2320-06.2006","article-title":"Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy.","volume":"26","author":"Sasaki","year":"2006","journal-title":"J. Neurosci."},{"key":"B157","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1093\/schbul\/sbq112","article-title":"Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia.","volume":"37","author":"Sathyasaikumar","year":"2011","journal-title":"Schizophr. Bull."},{"key":"B158","first-page":"1935","article-title":"Increased degradation of tryptophan in blood of patients with rheumatoid arthritis.","volume":"30","author":"Schroecksnadel","year":"2003","journal-title":"J. Rheumatol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.1073\/pnas.85.11.4079","article-title":"3-Hydroxyanthranilate oxygenase activity is increased in the brains of Huntington disease victims (kynurenines\/quinolinic acid\/excitotoins\/neurodegenerative disorders).","volume":"85","author":"Schwarcz","year":"1988","journal-title":"Neurobiology"},{"key":"B160","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S0378-4347(00)83173-4","article-title":"Fluorimetric micro-determination of kynurenic acid, an endogenous blocker of neurotoxicity, by high-performance liquid chromatography.","volume":"430","author":"Shibata","year":"1988","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"B161","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1046\/j.1471-4159.1998.70010299.x","article-title":"3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity.","volume":"70","author":"Shoki","year":"1998","journal-title":"J. Neurochem."},{"key":"B162","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/978-1-4615-0135-0_83","article-title":"ECNI GC-MS analysis of picolinic and quinolinic acids and their amides in human plasma, CSF, and brain tissue.","volume":"527","author":"Smythe","year":"2003","journal-title":"Adv. Exp. Med. Biol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1172\/JCI106043","article-title":"Serum kynurenine in rheumatoid arthritis.","volume":"48","author":"Spiera","year":"1969","journal-title":"J. Clin. Invest."},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-8-94","article-title":"Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?","volume":"8","author":"Steiner","year":"2011","journal-title":"J. Neuroinflamm."},{"key":"B165","first-page":"309","article-title":"Neuropharmacology of quinolinic and kynurenic acids.","volume":"45","author":"Stone","year":"1993","journal-title":"Pharmacol. Rev."},{"key":"B166","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1111\/j.1742-4658.2012.08487.x","article-title":"Kynurenine pathway inhibition as a therapeutic strategy for neuroprotection.","volume":"279","author":"Stone","year":"2012","journal-title":"FEBS J."},{"key":"B167","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/j.1471-4159.2005.03070.x","article-title":"Tryptophan metabolism and oxidative stress in patients with Huntington\u2019s disease.","volume":"93","author":"Stoy","year":"2005","journal-title":"J. Neurochem."},{"key":"B168","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/infdis\/jiz048","article-title":"Kynurenine is a cerebrospinal fluid biomarker for bacterial and viral central nervous system infections.","volume":"220","author":"S\u00fchs","year":"2019","journal-title":"J. Infect. Dis."},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1039\/c3mb70216b","article-title":"Identification of biomarkers for unstable angina by plasma metabolomic profiling.","volume":"9","author":"Sun","year":"2013","journal-title":"Mol. Biosyst."},{"key":"B170","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0021-9258(18)65070-7","article-title":"The conversion of kynurenic acid to quinaldic acid by humans and rats.","volume":"223","author":"Takahashi","year":"1956","journal-title":"J. Biol. Chem."},{"key":"B171","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1016\/S0021-9258(17)35696-X","article-title":"Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase.","volume":"261","author":"Takikawa","year":"1986","journal-title":"J. Biol. Chem."},{"key":"B172","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/0009-8981(59)90112-3","article-title":"The determination in urine of some metabolites of tryptophan-kynurenine, anthranilic acid and 3-hydroxyanthranilic acid-and reference to the presence of o-aminophenol in urine.","volume":"4","author":"Tompsett","year":"1959","journal-title":"Clin. Chim. Acta"},{"key":"B173","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3109\/21678421.2013.778554","article-title":"Mechanisms, models and biomarkers in amyotrophic lateral sclerosis.","volume":"14","author":"Turner","year":"2013","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"B174","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S1474-4422(11)70049-7","article-title":"Towards a neuroimaging biomarker for amyotrophic lateral sclerosis.","volume":"10","author":"Turner","year":"2011","journal-title":"Lancet Neurol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S1474-4422(08)70293-X","article-title":"Biomarkers in amyotrophic lateral sclerosis.","volume":"8","author":"Turner","year":"2009","journal-title":"Lancet Neurol."},{"key":"B176","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/science.aac4854","article-title":"NAD+ in aging, metabolism, and neurodegeneration.","volume":"350","author":"Verdin","year":"2015","journal-title":"Science"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-3851-4","article-title":"Activation of the kynurenine pathway is associated with poor outcome in Pneumocystis pneumonia patients infected with HIV: results of 2?months cohort study.","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040221","article-title":"Biomarkers of inflammation, immunosuppression and stress are revealed by metabolomic profiling of tuberculosis patients.","volume":"7","author":"Weiner","year":"2012","journal-title":"PLoS One"},{"key":"B179","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1600-079X.2006.00377.x","article-title":"Reduced oxidative damage in ALS by high-dose enteral melatonin treatment.","volume":"41","author":"Weishaupt","year":"2006","journal-title":"J. Pineal Res."},{"key":"B180","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s007020200014","article-title":"Increased neopterin production and tryptophan degradation in advanced Parkinson\u2019s disease.","volume":"109","author":"Widner","year":"2002","journal-title":"J. Neural Transm."},{"key":"B181","doi-asserted-by":"publisher","first-page":"32134","DOI":"10.18632\/oncotarget.16739","article-title":"Metabolic profiling and novel plasma biomarkers for predicting survival in epithelial ovarian cancer.","volume":"8","author":"Xie","year":"2017","journal-title":"Oncotarget"},{"key":"B182","doi-asserted-by":"publisher","first-page":"23","DOI":"10.5607\/en.2010.19.1.23","article-title":"Inactivation of aconitase by Tetrahydrobiopterin in DArgic Cells: relevance to PD.","volume":"19","author":"Yoon","year":"2010","journal-title":"Exp. Neurobiol."},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182638","article-title":"Epigenetic differences between monozygotic twins discordant for amyotrophic lateral sclerosis (ALS) provide clues to disease pathogenesis.","volume":"12","author":"Young","year":"2017","journal-title":"PLoS One"},{"key":"B184","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/j.1471-4159.1977.tb10664.x","article-title":"Effect of albumin binding and amino acid competition on tryptophan uptake into brain.","volume":"28","author":"Yuwiler","year":"1977","journal-title":"J. Neurochem."},{"key":"B185","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s00018-005-5417-4","article-title":"Functional polymorphisms of the brain serotonin synthesizing enzyme tryptophan hydroxylase-2.","volume":"63","author":"Zhang","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"B186","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/J.NBD.2013.03.008","article-title":"Melatonin inhibits the caspase-1\/cytochrome c\/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis.","volume":"55","author":"Zhang","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"B187","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3109\/0886022X.2013.790301","article-title":"Plasma Kynurenic Acid\/Tryptophan Ratio: a sensitive and reliable biomarker for the assessment of renal function.","volume":"35","author":"Zhao","year":"2013","journal-title":"Ren. Fail."},{"key":"B188","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2217\/bmm-2017-0280","article-title":"Increased kynurenine plasma concentrations and kynurenine-tryptophan ratio in mild-to-moderate chronic obstructive pulmonary disease patients.","volume":"12","author":"Zinellu","year":"2018","journal-title":"Biomark. Med."},{"key":"B189","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/aje\/kwv242","article-title":"Plasma biomarkers of inflammation, the kynurenine pathway, and risks of all-cause, cancer, and cardiovascular disease mortality.","volume":"183","author":"Zuo","year":"2016","journal-title":"Am. J. Epidemiol."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2019.01013\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T19:01:02Z","timestamp":1611255662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2019.01013\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,20]]},"references-count":189,"alternative-id":["10.3389\/fnins.2019.01013"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2019.01013","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,20]]},"article-number":"1013"}}